Welcome to BioSeeker Group!

Analytical Tool - Breast Cancer

Additional Information

Published Date Feb 21, 2012
Format PDF & Software Application
Publisher BioSeeker Group

Availability: In stock

€3,100.00

Quick Overview

The ultimate tool for serious players who would like to understand the current competitive field in breast cancer drug development.
Request free sample pages from Analytical Tool - Breast Cancer

"Analytical Tool - Breast Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in breast cancer R&D and business development. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.

Included in this advantageous package are two products already appreciated by many of our customers:


The Package Includes

  • A progress analysis on current and emerging drugs
  • Information on most companies active in breast cancer R&D
  • Information on key industry related breast cancer projects
  • Data from most important clinical trials
  • Information on early developmental stage projects
  • Possibility of performing advanced searches suited to your individual needs

This Tool will Assist You in:

  • Tracking cutting edge companies, therapies and new technologies
  • Rapid identification of partners & competitors
  • Laying down a comprehensive framework for further analysis of the field
  • Producing presentations surrounding the development of breast cancer therapeutics
  • Identifying emerging breast cancer products & key areas of pharmaceutical R&D

*This software application is a searchable database reflects the most recent advances in the field of breast cancer drug development, in order to help you perform your own analysis, go back to the source data for in-depth information, and present the research and development in tables and graphs suited for your own specific purposes. A significant advantage with BioSeeker’s software applications is that they provide you with well-structured information. Each pipeline drug/project has been carefully defined and classified in categories and subcategories. The main categories include therapy type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases, BioSeeker’s software applications give better overview, specific search capabilities and great dynamic reports.

Request free sample pages from Analytical Tool - Breast Cancer

Other selected research from the 'Analytical Tool' category:


Analytical Tool - Cancer Immunotherapy
A unique tool for analyzing the vast amount of strategic possibilities that have emerged in cancer immunotherapy. Learn More


Analytical Tool - Protein Kinase Inhibitors in Oncology
Adopt knowledge from this analysis to drive strategic planning decisions in PKI drug development in oncology. Learn More

Other selected research from the 'R&D' category:


IL-9 Signaling Pathway in Oncology Drug Pipeline Update 2012
BioSeeker Group have identified 48 companies plus partners who are today developing 40 IL-9 pathway targeting drugs in 151 developmental projects in cancer across 44 different targets. In addition, there is 1 suspended drug and another 20 drugs where development has been ceased. Learn More


IL-4 Signaling Pathway in Oncology Drug Pipeline Update 2012
BioSeeker Group have identified 130 companies plus partners who are today developing 157 IL-4 pathway targeting drugs in 409 developmental projects in cancer across 92 different targets. In addition, there are 3 suspended drugs and another 61 drugs where development has been ceased. Learn More

Other selected research from the 'Oncology' category:


Triple Analysis: Colorectal Cancer, Lymphoma and Pancreatic Cancer
This triple analysis focuses on cancer drug development strategies in Colorectal Cancer, Lymphoma and Pancreatic Cancer. Learn More


Analytical Tool - Cancer Vaccines
The ultimate tool for serious players who would like to understand the current competitive field in cancer vaccine development. Learn More